Skip to content

Use of Animal-Assisted Therapy to decrease cardiopulmonary pressures, neurohormone levels, and state anxiety in patients hospitalised with heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN26749623
Enrollment
76
Registered
2006-10-13
Start date
2001-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure Circulatory System Heart failure

Interventions

Group one: 12-minute visit from a volunteer with a therapy dog Group two: 12-minute visit from a volunteer Group three: control group, received usual care Data were collected at baseline, eight minut

Sponsors

Pet Care Trust Foundation (USA)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of heart failure requiring medical management with an indwelling pulmonary artery catheter 2. Age between 18 and 80 years 3. Ability to read, write, and speak English 4. Orientation status of alert and oriented to person, place, and time 5. Systemic Vascular Resistance (SVR) greater than 1200 dyne/sec/cm^-5 at least once within 12 hours from the start of data collection

Exclusion criteria

Exclusion criteria: 1. SVR less than 1200 dyne/sec/cm^-5 2. Allergies to dogs 3. Immunosuppression, defined as a white blood cell count of less than 4500 cells/mm^3 4. Infection as determined by an elevated white blood cell count exceeding 11,000 cells/mm^3 5. Body temperature greater than 38 degrees Celsius 6. Decreased level of consciousness

Design outcomes

Primary

MeasureTime frame
1. Haemodynamics 2. Neurohormonal levels 3. State anxiety

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026